.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 7,863,287

« Back to Dashboard

Claims for Patent: 7,863,287

Title:Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
Abstract: The present invention is directed to a pharmaceutical composition and method for the treatment of rhinitis and cold-like symptoms which includes a non-steroidal anti-inflammatory drug (NSAID), a decongestant, and an antihistamine. It has been found that an NSAID enhances the activity of a decongestant and an anti-histamine, thus permitting a reduction in either or both in administration of separate dosage forms. The same enhancement can also occur with an anti-tussitive. Thus, the effective amount of the decongestant or the antihistamine or both is less than about 75% of an amount present in an approved dose of the decongestant or the antihistamine, or both, relative to an amount of the NSAID corresponding to about 100% of the amount present in a normal strength dosage form of the NSAID.
Inventor(s): Berlin; Roger G. (Mendham, NJ)
Assignee: Wyeth LLC (Madison, NJ)
Application Number:10/740,386
Patent Claims: 1. A unit dosage form comprising about 18 to about 33 mg pseudoephedrine, about 1.2 to about 2.2 mg chlorpheniramine, and about 100 to about 200 mg ibuprofen per said unit dosage form.

2. The unit dosage form of claim 1 in the form of a tablet, trochet, dispersion, suspension, solution, elixir, capsule or patch.

3. The unit dosage form of claim 1 further comprising at least one excipient selected from the group consisting of lubricants, disintegrants, glidents, adsorbents, and mixtures thereof.

4. The unit dosage form of claim 1 comprising about 21 to about 30 mg pseudoephedrine, about 1.4 to about 2.0 mg chlorpheniramine, and about 100 to about 200 mg ibuprofen per said unit dosage form.

5. The unit dosage form of claim 4 in the form of a tablet, trochet, dispersion, suspension, solution, elixir, capsule or patch.

6. The unit dosage form of claim 4 further comprising at least one excipient selected from the group consisting of lubricants, disintegrants, glidents, adsorbents, and mixtures thereof.

7. The unit dosage form of claim 4 comprising about 30 mg pseudoephedrine, about 2.0 mg chlorpheniramine, and about 200 mg ibuprofen per said unit dosage form.

8. The unit dosage form of claim 7 in the form of a tablet, trochet, dispersion, suspension, solution, elixir, capsule or patch.

9. The unit dosage form of claim 7 further comprising at least one excipient selected from the group consisting of lubricants, disintegrants, glidents, adsorbents, and mixtures thereof.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc